530 related articles for article (PubMed ID: 22105783)
1. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
[TBL] [Abstract][Full Text] [Related]
2. Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Jensen JS; Bjerre M
Am Heart J; 2012 Nov; 164(5):786-92. PubMed ID: 23137511
[TBL] [Abstract][Full Text] [Related]
3. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
[TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.
Lyngbæk S; Marott JL; Møller DV; Christiansen M; Iversen KK; Clemmensen PM; Eugen-Olsen J; Jeppesen JL; Hansen PR
Am J Cardiol; 2012 Dec; 110(12):1756-63. PubMed ID: 22981263
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).
Antoni ML; Hoogslag GE; Boden H; Liem SS; Boersma E; Fox K; Schalij MJ; Bax JJ; Delgado V
Am J Cardiol; 2012 Jan; 109(2):187-94. PubMed ID: 22244127
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Pedersen S; Mogelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Sørensen TB; Iversen A; Hvelplund A; Jensen JS
Cardiology; 2012; 123(1):31-8. PubMed ID: 22964478
[TBL] [Abstract][Full Text] [Related]
9. Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
Shen XH; Chen Q; Shi Y; Li HW
Chin Med J (Engl); 2010 Dec; 123(23):3438-43. PubMed ID: 22166528
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Hoebers LP; Damman P; Claessen BE; Vis MM; Baan J; van Straalen JP; Fischer J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am J Cardiol; 2012 Jan; 109(1):53-9. PubMed ID: 21944676
[TBL] [Abstract][Full Text] [Related]
11. Effect of implementing routine early invasive strategy on one-year mortality in patients with acute myocardial infarction.
Aune E; Endresen K; Fox KA; Steen-Hansen JE; Roislien J; Hjelmesaeth J; Otterstad JE
Am J Cardiol; 2010 Jan; 105(1):36-42. PubMed ID: 20102887
[TBL] [Abstract][Full Text] [Related]
12. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
[TBL] [Abstract][Full Text] [Related]
14. Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction.
Velders MA; Boden H; van Boven AJ; van der Hoeven BL; Heestermans AA; Cannegieter SC; Umans VA; Jukema JW; Hofma SH; Schalij MJ
Am J Cardiol; 2013 Feb; 111(3):312-8. PubMed ID: 23159214
[TBL] [Abstract][Full Text] [Related]
15. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Planer D; Mehran R; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Reyes SL; Stone GW
Am J Cardiol; 2011 Oct; 108(8):1068-74. PubMed ID: 21798494
[TBL] [Abstract][Full Text] [Related]
17. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
18. Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Piestrzeniewicz K; Luczak K; Maciejewski M; Drozdz J
Cardiol J; 2010; 17(1):49-56. PubMed ID: 20104457
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction).
Antonsen L; Jensen LO; Thayssen P; Christiansen EH; Junker A; Tilsted HH; Terkelsen CJ; Kaltoft A; Maeng M; Hansen KN; Ravkilde J; Lassen JF; Madsen M; Sørensen HT; Thuesen L
Am J Cardiol; 2011 Nov; 108(10):1395-400. PubMed ID: 21890087
[TBL] [Abstract][Full Text] [Related]
20. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Zhao L; Wang L; Zhang Y
J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
